Work

Prospective, Randomized Comparison of High-Dose Chemotherapy With Stem-Cell Support Versus Intermediate-Dose Chemotherapy After Surgery and Adjuvant Chemotherapy in Women With High-Risk Primary Breast Cancer: A Report of CALGB 9082, SWOG 9114, and NCIC MA-13

Year: 2005

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.10.202

Authors: William P. Peters, Gary L. Rosner, James J. Vredenburgh, Elizabeth J. Shpall, Michael Crump, Paul G. Richardson, Michael W. Schuster, Lawrence B. Marks, Constance Cirrincione, Larry Norton, I.C. Henderson, Richard L. Schilsky, David D. Hurd

Institutions: Duke University, Princess Margaret Cancer Centre, Dana-Farber Cancer Institute, Duke Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1033243903, G1072356872, Southwest Oncology Group, G10814802, SOUTHWEST ONCOLOGY GROUP, G1375689152, WUMC Cancer and Leukemia Group B, G152477846, G1549000524, CANCER AND LEUKEMIA GROUP B, G1689128559, Cancer and Leukemia Group B, G1911575068, G192656225, G199746015, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, G220937036, G2296793909, G237383067, G2397742718, G2405064429, North Shore CCOP, G2562936776, G257334932, G260759372, Cancer and Leukemia Group B, G2647518335, G268786457, WESTERN ONCOLOGY RESEARCH CONSORTIUM, G2745671310, Southwest Oncology Group U10 Member Site, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, G313314762, CANCER AND LEUKEMIA GROUP B--MOUNT SINAI, Cancer and Leukemia Group B, G413009747, G4192246825, SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS, G425646771, G4292856267, G436504642, G4530377164, G4670716055, Canadian Contribution to NCI Intergroup Program, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B: RPMI/SUNYAB, G5125348268, CANCER AND LEUKEMIA GROUP B, G5504618518, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, G5653597704, Cancer and Leukemia Group B, SOUTHWEST ONCOLOGY GROUP--COOP GROUP CLINICAL STUDY, UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM, G591690631, CANCER AND LEUKEMIA GROUP B (CALGB), CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, SOUTHWEST ONCOLOGY GROUP, University of Colorado Southwest Oncology Group, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, CANCER AND LEUKEMIA GROUP B, G739544170, Hawaii Minority-Based Clinical Community Oncology Program, CANCER AND LEUKEMIA GROUP B--MINNESOTA ONCOLOGY GROUP, SOUTHWEST ONCOLOGY GROUP STUDY, Cancer and Leukemia Group B, Virginia Mason Community Clinical Oncology Program, G791413246, G802218729, CANCER AND LEUKEMIA GROUP B, G860872252, G866232813, SOUTHWEST ONCOLOGY GROUP, G877081928, G877907214, PARTICIPATE AS MEMBER OF SOUTHWEST ONCOLOGY GROUP, G926666752, G973482110, G979369470

OpenAlex ID: W2151933302

FWCI: 4.981

Cites: 34

Cited by: 100

Related to: 10